Vahid Shahnavaz

Vahid Shahnavaz

Auto-generated profile, based on publicly available information

Vahid Shahnavaz

Department of Microbiology and Virology School of Medicine Alborz University of Medical Sciences Karaj Iran

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2026 in Cardiology Research and Practice
Verified
Journal Article
Open access
EAElmira Jafari Afshar
Elmira Jafari Afshar
ATAmirhossein Tayebi
Amirhossein Tayebi
PSParham Samimisedeh
Parham Samimisedeh
VSVahid Shahnavaz
Vahid Shahnavaz
AMAryan Madady
Aryan Madady
NHNeda Shafiabadi Hassani
Neda Shafiabadi Hassani
Background: Left ventricular pseudoaneurysm (LVPA) is a rare but life‐threatening complication of myocardial infarction (MI). We pooled clinical and imaging findings of post‐MI LVPA reported in case reports/series and compared them with findings in post‐MI left ventricular aneurysm (LVA). Method: We comprehensively searched the literature published since 1991 on online databases. Individual‐level patient data (IPD) and aggregated‐level data (AD) studies were combined through a two‐stage meta‐analysis method. Results: We identified 379 eligible articles on LVPA ( N = 504 patients). LVPA patients were predominantly male (70.4%) with a mean age of 65.4 years (95% CI: 62.4, 68.4). The time interval between the last MI and the diagnosis of LVPA varied from one day to 20 years; 54.5% fell into the acute/subacute category. On echocardiography, the most frequent locations of LVPA were posterior (34.5%) and inferior (21.2%). The average dimensions were 5.7 and 7.3 cm. On MRI, late gadolinium enhancement, primarily pericardial, was observed in 84% of patients. Arrhythmia was more frequently observed in LVA than LVPA (33.8% vs. 1%). Echocardiography showed a lower diagnostic value in LVPA than LVA (sensitivity: 81.4% vs. 97.5%). A higher percentage of LVPA than the LVA group died during hospitalization (13.8% vs. 4.7%) or after discharge (17.5% vs. 9.0%). Conclusion: LVPA is probably located on the posterior and inferior segments in most patients, contrary to LVA, which mainly involves the anterior and apical segments. Arrhythmia is likely a common clinical finding in LVA but not LVPA. Echocardiography may not always detect LVPA in 20% of patients.

26 February 2023 in medRxiv
Verified
Preprint
Open access
PDF file
EAElmira Jafari Afshar
Elmira Jafari Afshar
ATAmirhossein Tayebi
Amirhossein Tayebi
PSParham Samimisedeh
Parham Samimisedeh
VSVahid Shahnavaz
Vahid Shahnavaz
AMAryan Madady
Aryan Madady
NHNeda Shafiabadi Hassani
Neda Shafiabadi Hassani
Background: Left ventricular pseudoaneurysm (LVPA) is a rare but life-threatening complication of myocardial infarction (MI). Given the similarities in the clinical presentations and the appearance of the cardiac imaging, differentiation of LVPA from left ventricular aneurysm (LVA) remains a challenge but is imperative for timely management. We summarized and compared clinical and imaging findings of post-MI LVPA and LVA. Method: We performed a comprehensive search of the literature in PubMed and Scopus databases using combinations of key terms covering LVPA / LVA and MI. In both LVA and LVPA, individual-level patient data (IPD) and aggregated-level data (AD) studies were combined through a two-stage analysis method. Results: We identified 379 eligible articles on LVPA (N= 504 patients) and 120 on LVA (n= 20,968). Based on our pooled analysis, cases were predominantly male in both groups (70.4%and 75.7 %, respectively), but LVPA patients were roughly older (Mean (95% Confidence interval (CI): (65.4 (62.4, 68.4) vs. 60.8 (58.9, 62.8) years, respectively) and had a shorter mean time interval from MI to diagnosis than LVA (5.1 vs. 27.8, months). At presentation, while 33.8 (95% CI: 22.1, 46.0) of patients with LVA had arrhythmia, only 1.0 % (95% CI: 0.0, 2.9) of LVPA patients presented with this symptom. LVPA compared to the LVA group, more frequently had ST-segment elevation (43.2% Vs. 28.6, respectively) but less frequently ECG signs of the old MI (42.2% Vs. 61.9, respectively). Echocardiography showed a lower diagnostic value in LVPA than LVA (Sensitivity: 81.4% Vs. 97.5%). Contrary to LVA, LVPA is mainly located on posterior and inferior segments based on echocardiography evaluations. On Cardiac MRI, the majority of LVPA patients had pericardial LGE (84.0% (CI 95%: 63.9, 95.5)). A higher percentage of LVPA compared to the LVA group dead during hospitalization (13.8% vs. 4.7%, respectively) or after discharge (17.5%vs. vs. 9.0%, respectively). Conclusion: Arrhythmia is likely common in LVA patients at presentation but not in LVPA. LVPA is mainly located on the posterior and inferior, and LVA is on the anterior and apical segments. On cardiac MRI, pericardial LGE may suggest the presence of LVPA rather than LVA in suspected patients.

29 December 2025 in Jundishapur Journal of Microbiology
Verified
Journal Article
Open access
PDF file
RSRamin Shahbahrami
Ramin Shahbahrami
ABAtefeh Bahavar
Atefeh Bahavar
ALArash Letafati
Arash Letafati
YDYousef Douzandegan
Yousef Douzandegan
VSVahid Shahnavaz
Vahid Shahnavaz
MNMehdi Norouzi
Mehdi Norouzi
Background: Adult T-cell leukemia/lymphoma (ATLL) is a hematologic malignancy associated with human T-cell lymphotropic virus type 1 (HTLV-1) infection. Gene expression changes play a role in its pathogenesis. Objectives: In this study, we examined the gene expression profiles of alpha-actinin-4 (ACTN4), Tuberous Sclerosis Complex 2 (TSC2), C-X-C chemokine receptor type 4 (CXCR4), and Activating Transcription Factor 1 (ATF1) in Iranian ATLL patients for the first time, contrasting the findings with those from healthy controls. Methods: This case-control study (2023 - 2024) included 20 male Iranian participants (10 ATLL patients and 10 healthy controls). From each participant, 6 ml of whole blood was collected. Samples from eligible participants were screened for HTLV-1 infection using enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction (PCR). RNA was extracted and complementary DNA (cDNA) synthesis was performed. The expression of ACTN4, TSC2, CXCR4, ATF1, and viral HBZ genes was measured by Real-time PCR, using RPLP0 as the reference gene. Results: Expression of TSC2 and ACTN4 genes was significantly decreased in ATLL patients compared to healthy controls (TSC2: mean ± SD: 0.00003 ± 0.00004 vs. 0.00006 ± 0.00004, P < 0.05; ACTN4: 0.0129 ± 0.024 vs. 0.0207 ± 0.009, P < 0.05); CXCR4 and ATF1 expression levels were slightly increased but not significantly different between groups (CXCR4: 0.147 ± 0.154 vs. 0.139 ± 0.09, P > 0.05; ATF1: 0.0028 ± 0.0029 vs. 0.0015 ± 0.0009, P > 0.05). Conclusions: Dysregulation of target genes in ATLL patients suggests HTLV-1 involvement in disease progression by modulating host cellular pathways. Although CXCR4 and ATF1 showed non-significant upward trends, the observed downregulation of TSC2 and ACTN4 warrants further investigation in a larger sample size to clarify their potential roles in ATLL pathogenesis.